inhibitor; redox; 11beta-hydroxysteroid dehydrogenase; endoplasmic reticulum; glucose-6-phosphate; pentose-phosphate pathway; NADPH; bile acid
Odermatt Alex, Klusonova Petra (2015), 11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story., in
The Journal of steroid biochemistry and molecular biology, 151, 85-92.
Tsachaki Maria, Birk Julia, Egert Aurélie, Odermatt Alex (2015), Determination of the topology of endoplasmic reticulum membrane proteins using redox-sensitive green-fluorescence protein fusions., in
Biochimica et biophysica acta, 1853(7), 1672-82.
Penno Carlos A, Morgan Stuart A, Rose Adam J, Herzig Stephan, Lavery Gareth G, Odermatt Alex (2014), 11β-Hydroxysteroid dehydrogenase-1 is involved in bile acid homeostasis by modulating fatty acid transport protein-5 in the liver of mice., in
Molecular metabolism, 3(5), 554-564.
Seibert Julia, Hysek Cédric M, Penno Carlos A, Schmid Yasmin, Kratschmar Denise V, Liechti Matthias E, Odermatt Alex (2014), Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects., in
Neuroendocrinology, 100(1), 17-25.
Legeza Balázs, Balázs Zoltán, Odermatt Alex (2014), Fructose promotes the differentiation of 3T3-L1 adipocytes and accelerates lipid metabolism., in
FEBS letters, 588(3), 490-496.
Vuorinen Anna, Engeli Roger, Meyer Arne, Bachmann Fabio, Griesser Ulrich J, Schuster Daniela, Odermatt Alex (2014), Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors., in
Journal of medicinal chemistry, 57(14), 5995-6007.
Nashev Lyubomir G, Atanasov Atanas G, Baker Michael E, Odermatt Alex (2013), Cysteine-10 on 17 β -Hydroxysteroid Dehydrogenase 1 Has Stabilizing Interactions in the Cofactor Binding Region and Renders Sensitivity to Sulfhydryl Modifying Chemicals., in
International journal of cell biology, 2013, 769536-769536.
Penno Carlos A, Morgan Stuart A, Vuorinen Anna, Schuster Daniela, Lavery Gareth G, Odermatt Alex (2013), Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acid., in
Journal of lipid research, 54(10), 2874-2883.
Hofer Sandra, Kratschmar Denise V, Schernthanner Brigitte, Vuorinen Anna, Schuster Daniela, Odermatt Alex, Easmon Johnny (2013), Synthesis and biological analysis of benzazol-2-yl piperazine sulfonamides as 11β-hydroxysteroid dehydrogenase 1 inhibitors., in
Bioorganic & medicinal chemistry letters, 23(19), 5397-5400.
Pandya Keyur, Dietrich David, Seibert Julia, Vederas John C, Odermatt Alex (2013), Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists., in
Bioorganic & medicinal chemistry, 21(21), 6274-6281.
Legeza Balázs, Balázs Zoltán, Nashev Lyubomir G, Odermatt Alex (2013), The microsomal enzyme 17β-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase., in
Endocrinology, 154(1), 205-13.
Chantong Boonrat, Kratschmar Denise V, Nashev Lyubomir G, Balazs Zoltan, Odermatt Alex (2012), Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells., in
Journal of neuroinflammation, 9, 260-260.
Purpose and aim of the projectThe reduced pyridine nucleotide NADPH acts as cofactor for a multitude of essential reduction reactions. The enzymes involved in NADPH synthesis and regeneration, and the metabolic reactions utilizing NADPH in the cytoplasm, have been extensively investigated. In contrast, much less is known on NADPH generation and utilization in the endoplasmic reticulum (ER). The recent recognition of the role of hexose-6-phosphate dehydrogenase (H6PDH) in generating luminal NADPH provided an explanation for the maintenance of the NADP+/NADPH pool in the ER. Biochemical evidence further indicated the existence of all enzymes of the pentose-phosphate pathway in the ER. However, so far only H6PDH has been characterized at the molecular level, and further research is required to elucidate this pathway in the ER. Recent cell-based experiments and studies with transgenic mice lacking H6PDH demonstrated the importance of luminal NADPH for glucocorticoid activation. Moreover, H6PDH-deficient mice suffered from myopathy and activation of the unfolded-protein response (UPR), whereby glucocorticoid-independent impairment of ER redox regulation was suggested as underlying mechanism. H6PDH activity depends on glucose-6-phosphate (G6P) availability. G6P can be provided from the cytoplasm by the G6P-transporter (G6PT) or, alternatively, by a luminal isomerase converting fructose-6-phosphate (F6P) to G6P that we characterized recently. Nevertheless, the gene encoding this enzyme remains to be identified. We have previously shown that H6PDH determines the reaction direction of 11beta-hydroxysteroid dehydrogenase 1 (11b-HSD1) to catalyze the reduction of inactive 11-keto- to active 11b-hydroxyglucocorticoids. Also, we found that 11b-HSD1 metabolizes several other substrates, including oxysterols, bile acids and carbonyl containing xenobiotics. The physiological relevance of these additional functions is poorly understood and requires further investigation.So far, 11b-HSD1 is the only NADPH-dependent enzyme in the ER that has been thoroughly characterized. Evidence from H6PDH-deficient transgenic mice and cell-based experiments emphasizes the existence of other NADPH-dependent luminal enzymes. Therefore, we aim to further characterize the mechanisms of NADPH generation in the ER and to search for enzymes that utilize NADPH in this compartment. We propose to:I.elucidate the mechanisms involved in the regulation of NADPH generation in the ER by:a) an attempt to identify the gene for the luminal hexose-6-phosphate isomerase;b) characterization of the luminal 6-phosphogluconate dehydrogenase (6PGDH) activity;c) trying to identify enzymes other than H6PDH that generate NADPH in the ER; andII.characterize NADPH-dependent reactions in the ER by:a) determination of the impact of 11b-HSD1 on bile acid metabolism and profiles;b) determination of 17b-HSD3 membrane topology and functional impact of H6PDH;c) performing a search for substrate(s) of 11b-HSD3 and elucidating its function; andd) trying to identify additional ER luminal reductases that utilize NADPH.For the identification of luminal enzymes we will use rat liver microsomes and apply an activity-guided purification strategy. A combination of fractionation, affinity purification, gel-electrophoretic separation and identification by mass spectrometry will be applied. Upon identification, expression plasmids will be constructed, followed by functional characterization. The proposed research should significantly enhance the current knowledge on NADPH generation and utilization in the ER. The expected findings are relevant regarding the understanding of the coupling between cellular energy state, hormonal regulation, ER redox regulation, and oxidative stress-induced damage. Disturbed functions of the enzymes investigated are likely to be associated with metabolic disturbances.